COMMUNIQUÉS West-GlobeNewswire

-
Santhera’s Partner Catalyst Pharmaceuticals Launches AGAMREE® (Vamorolone) in the United States
14/03/2024 -
Hyloris Présente ses Résultats Annuels pour 2023 et ses Perspectives
14/03/2024 -
Hyloris Reports Full Year Results for 2023 & Provides Business Outlook
14/03/2024 -
Pharming Group reports fourth quarter and full year 2023 financial results
14/03/2024 -
Communication at the request of the FSMA on the transactions with Qliniq
14/03/2024 -
Communiqué à la requête de la FSMA sur les transactions avec QliniQ
14/03/2024 -
Antheia et Olon poursuivent leur partenariat pour la biofabrication de matières premières essentielles et de principes actifs pharmaceutiques d'Antheia pour les médicaments essentiels
14/03/2024 -
Mesoblast Successfully Completes Placement and Accelerated Entitlement Offer
14/03/2024 -
BioSyent Releases Financial Results for Fourth Quarter and Full Year 2023
13/03/2024 -
New Employee Elected Directors to the Board of Zealand Pharma A/S
13/03/2024 -
Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
13/03/2024 -
Transactions with shares and linked securities in Genmab A/S made by managerial employees and their closely associated persons
13/03/2024 -
Constitution of the Board of Directors in Genmab A/S, Grant of Restricted Stock Units to Board Members and Employees and Grant of Warrants to Employees in Genmab
13/03/2024 -
IRADIMED CORPORATION To Participate at the 36th Annual Roth Conference
13/03/2024 -
Enzo Biochem Reports Second Quarter Fiscal 2024 Results and Provides Business Update
13/03/2024 -
Lexeo Therapeutics Announces Closing of Oversubscribed $95.0 Million Equity Financing
13/03/2024 -
Anika Reports Fourth Quarter and Year-End 2023 Financial Results
13/03/2024 -
Mineralys Therapeutics to Announce Fourth Quarter and Full Year 2023 Financial Results and Host Conference Call on Thursday, March 21, 2024
13/03/2024 -
electroCore Announces Fourth Quarter and Full Year 2023 Financial Results
13/03/2024
Pages